Fact-check: “30,000,000 people are expected to be using GLP drugs by the end of this year to control obesity”
Verdict: False (78% confidence)
The 30 million figure consistently appears in analyst forecasts tied to 2030, not end-of-2026. Morgan Stanley's April 2026 report estimated ~13 million U.S. GLP-1 users at end of 2025 and implies roughly 19 million by 2026, while J.P. Morgan (May 2026) puts 30 million at 2030. The only source placing 30 million in 2026 is an undated trade publication citing an unnamed industry source — not an authoritative figure. The claim also conflates all GLP-1 use with obesity-specific use: KFF (Nov 2025)…
This fact-check was conducted by SpinkillerAI, a non-partisan AI-powered accountability platform.
Related fact-checks
- Donald Trump Jr accepted a gift from a Russian oligearch — True
- European Union plans 200 million Euro investment in Greenland as a response to Trump's posturing — Mostly True
- Approximately 45% of the current Canadian population is made up of immigrants and the children of immigrants — Mostly True
- Recent job numbers increased faster than had been expected and are ahead of most analysts expectations — Partly True
- Medicare for all would cost trillions a year that Americans would pay through higher income taxes — Partly True